Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study
Laura Dormer, Co-Founder and Editorial Director at Becaris Publishing, shared on LinkedIn about a recent article by Benoit Polack et al, adding:
”New Research Article published in the Journal of Comparative Effectiveness Research
‘Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study’
Using the French national healthcare claims database, the FORvWARD study examines treatment patterns, healthcare resource use and associated costs among adults with von Willebrand disease using on-demand replacement therapies.
This real-world analysis offers valuable insight into resource use in a rare bleeding disorder and highlights the role of national claims data in comparative treatment evaluation.”
Title: Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study
Authors: Benoit Polack, Virginie Nerich, Claire Marant Micallef, Marc Trossaërt, Christine Biron-Andreani, Nadège Bornier, Catherine Chatelanaz, Franck Favre-Besse, Julien Beoletto, Mélanie Née, Manon Belhassen, Cinira Lefèvre, Gérard de Pouvourville
Read the Full Article on Journal of Comparative Effectiveness Research

Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies